These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8588125)

  • 21. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
    Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
    J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the
    Bazot Q; Paschos K; Allday MJ
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29367247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus.
    Tsokos GC; Magrath IT; Balow JE
    J Immunol; 1983 Oct; 131(4):1797-801. PubMed ID: 6311898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-Time PCR of cytomegalovirus and Epstein-Barr virus in adult Egyptian patients with systemic lupus erythematosus.
    Mohamed AE; Hasen AM; Mohammed GF; Elmaraghy NN
    Int J Rheum Dis; 2015 May; 18(4):452-8. PubMed ID: 24341363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.
    Draborg AH; Lydolph MC; Westergaard M; Olesen Larsen S; Nielsen CT; Duus K; Jacobsen S; Houen G
    PLoS One; 2015; 10(9):e0138753. PubMed ID: 26402865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus.
    Llorente L; Richaud-Patin Y; Couderc J; Alarcon-Segovia D; Ruiz-Soto R; Alcocer-Castillejos N; Alcocer-Varela J; Granados J; Bahena S; Galanaud P; Emilie D
    Arthritis Rheum; 1997 Aug; 40(8):1429-35. PubMed ID: 9259422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus.
    al-Janadi M; Raziuddin S
    J Rheumatol; 1993 Nov; 20(11):1885-91. PubMed ID: 7508509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr-virus-transformed lymphoblastoid cell lines derived from patients with X-linked agammaglobulinaemia and Wiskott-Aldrich syndrome: responses to B cell growth and differentiation factors.
    Lau YL; Shields JG; Levinsky RJ; Callard RE
    Clin Exp Immunol; 1989 Feb; 75(2):190-5. PubMed ID: 2539277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of autoantibody-producing cell lines from peripheral blood lymphocytes of patients with systemic lupus erythematosus.
    Hirano T; Teraoka O; Teranishi T; Tsuyuguchi I; Tohda H; Oikawa A
    Microbiol Immunol; 1980; 24(9):879-86. PubMed ID: 6971392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probing the normal and autoimmune B cell repertoire with Epstein-Barr virus. Frequency of B cells producing monoreactive high affinity autoantibodies in patients with Hashimoto's disease and systemic lupus erythematosus.
    Nakamura M; Burastero SE; Ueki Y; Larrick JW; Notkins AL; Casali P
    J Immunol; 1988 Dec; 141(12):4165-72. PubMed ID: 2848890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.
    Gibbons DL; Rowe M; Cope AP; Feldmann M; Brennan FM
    Eur J Immunol; 1994 Aug; 24(8):1879-85. PubMed ID: 8056047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Platelet Binding to Lymphocytes with B Cell Abnormalities and Clinical Manifestations in Systemic Lupus Erythematosus.
    Zamora C; Toniolo E; Diaz-Torné C; Cantó E; Magallares B; Ortiz MA; Perea L; Corominas H; Vidal S
    Mediators Inflamm; 2019; 2019():2473164. PubMed ID: 30944545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in the phenotype and immunoglobulin secretion of human B cells following co-culture with cells of an EBV+ lymphoblastoid line or fusion with mouse plasmacytoma cells. Studies in short-term and long-term culture.
    Ling NR; Lowe JA
    Clin Exp Immunol; 1989 Feb; 75(2):311-6. PubMed ID: 2539279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of Epstein-Barr virus transformed B cell lines from patients with Alzheimer's disease and age-matched controls.
    Ounanian A; Guilbert B; Seigneurin JM
    Mech Ageing Dev; 1992 Mar; 63(1):105-16. PubMed ID: 1318479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines.
    Estrov Z; Kurzrock R; Pocsik E; Pathak S; Kantarjian HM; Zipf TF; Harris D; Talpaz M; Aggarwal BB
    J Exp Med; 1993 Mar; 177(3):763-74. PubMed ID: 8382256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell growth effects of Epstein-Barr virus leader protein.
    Allan GJ; Inman GJ; Parker BD; Rowe DT; Farrell PJ
    J Gen Virol; 1992 Jun; 73 ( Pt 6)():1547-51. PubMed ID: 1318948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detecting Epstein-Barr virus DNA from peripheral blood mononuclear cells in adult patients with systemic lupus erythematosus in Taiwan.
    Yu SF; Wu HC; Tsai WC; Yen JH; Chiang W; Yuo CY; Lu SN; Chiang LC; Chen CJ
    Med Microbiol Immunol; 2005 May; 194(3):115-20. PubMed ID: 15378356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NADPH oxidase activity and cytochrome b558 content of human Epstein-Barr-virus-transformed B lymphocytes correlate with expression of genes encoding components of the oxidase system.
    Condino-Neto A; Newburger PE
    Arch Biochem Biophys; 1998 Dec; 360(2):158-64. PubMed ID: 9851826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.